![Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record](https://www.enr.com/ext/resources/Issues/MidAtlantic_Issues/2018/10-October/22-Oct/teva-pilot-plant01.jpg?height=635&t=1539627719&width=1200)
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
![Why Teva Pharmaceutical Industries, SolarEdge Technologies, and Overstock.com Jumped Today | The Motley Fool Why Teva Pharmaceutical Industries, SolarEdge Technologies, and Overstock.com Jumped Today | The Motley Fool](https://g.foolcdn.com/editorial/images/473294/teva-logo.png)
Why Teva Pharmaceutical Industries, SolarEdge Technologies, and Overstock.com Jumped Today | The Motley Fool
![Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct](https://public.newsdirect.com/788028598/8k5IgnWp.jpg)
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg?download=1)